About Altay Therapeutics
Altay Therapeutics is a private company based in San Carlos, California. It has reported $15,738,155 raised in one offering on Form D since October 2026. Its chief executive is James Breitmeyer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Oct 2, 2026 | $15,738,155of $45.0M target | 19 | $828K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Altay Therapeutics's Form D filed Oct 2, 2026.
AO
EB
Eric Bjerkholt
Director
MG
Mike Grey
Executive Chair
Ester Sklarsky
Board Director
AK
CJ
Chelsea Johnson
Director